Endothelin A Receptor Antagonists in Congestive Heart Failure: Blocking the Beast while Leaving the Beauty Untouched?

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Heart Failure Reviews

• Publication date

  2001-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1023/A:1011456309039PMID 11447305
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma Endothelin Determination as a Prognostic Indicator of 1-Year Mortalit After Acute Myocardial Infarction

  2005cited by this paper
• Venous endothelin receptor function in patients with chronic heart failure.

  2000cited by this paper
• Acute hemodynamic and neurohumoral effects of selective ETA receptor blockade in patients with congestive heart failure

  2000cited by this paper
• Contrasting inotropic effects of endogenous endothelin in the normal and failing human heart: studies with an intracoronary ET(A) receptor antagonist.

  2000cited by this paper
• Acute hemodynamic and neurohumoral effects of selective ET(A) receptor blockade in patients with congestive heart failure. ET 003 Investigators.

  2000cited by this paper
• Chronic ETA receptor blockade attenuates cardiac hypertrophy independently of blood pressure effects in renovascular hypertensive rats.

  1999cited by this paper
• Chronic endothelin receptor antagonism preserves coronary endothelial function in experimental hypercholesterolemia.

  1999cited by this paper
• The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people.

  1999cited by this paper
• Vasoconstriction to endogenous endothelin-1 is increased in the peripheral circulation of patients with essential hypertension.

  1999cited by this paper
• Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group.

  1999cited by this paper
• Endothelin B receptors are functionally important in mediating vasoconstriction in the systemic circulation in patients with left ventricular systolic dysfunction.

  1999cited by this paper
• The temporal requirement for endothelin receptor-B signalling during neural crest development

  1999cited by this paper
• Identification of a genetic risk factor for idiopathic dilated cardiomyopathy. Involvement of a polymorphism in the endothelin receptor type A gene. CARDIGENE group.

  1999cited by this paper
• Vasoconstrictor effect of endothelin-1 in human skin: role of ETA and ETB receptors.

  1999cited by this paper
• Endothelin-1 potentiates human smooth muscle cell growth to PDGF: effects of ETA and ETB receptor blockade.

  1999cited by this paper
• Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

  1999cited by this paper
• Systemic blockade of the endothelin-B receptor increases peripheral vascular resistance in healthy men.

  1999cited by this paper
• Upregulated expression of cardiac endothelin-1 participates in myocardial cell growth in Bio14.6 Syrian cardiomyopathic hamsters.

  1999cited by this paper
• Polymorphisms of the endothelin-A and -B receptor genes in relation to blood pressure and myocardial infarction: the Etude Cas-Témoins sur l'Infarctus du Myocarde (ECTIM) Study.

  1999cited by this paper
• Endothelin-1 and its mRNA in the wall layers of human arteries ex vivo.

  1999cited by this paper
• Expression of endothelin-1, endothelin-converting enzyme, and endothelin receptors in chronic heart failure.

  1999cited by this paper
• Quantitative association between a newly identified molecular variant in the endothelin-2 gene and human essential hypertension.

  1999cited by this paper
• Nitric Oxide Synthesis and by Endothelin-B Receptor Blockade Mediated Vasodilatation Is Attenuated by Inhibition of − Endothelin-A Receptor Antagonist

  1998cited by this paper
• Cranial and cardiac neural crest defects in endothelin-A receptor-deficient mice.

  1998cited by this paper
• Reduced pulmonary clearance of endothelin-1 contributes to the increase of circulating levels in heart failure secondary to myocardial infarction.

  1998cited by this paper
• Modulatory effects of endothelin on baroreflex activation in the nucleus of the solitary tract.

  1998cited by this paper
• Chronic oral endothelin type A receptor antagonism in experimental heart failure.

  1998cited by this paper
• Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice.

  1998cited by this paper
• Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure.

  1998cited by this paper
• Endothelin receptors in the failing and nonfailing human heart.

  1998cited by this paper
• Expression of endothelin-1 and endothelin-converting enzyme-1 mRNAs and proteins in failing human hearts.

  1998cited by this paper
• Effect of endothelin-1 on exercise-induced vasodilation in normal subjects and in patients with heart failure.

  1998cited by this paper
• Altered expression of isoforms of myosin heavy chain mRNA in the failing rat heart is ameliorated by chronic treatment with an endothelin receptor antagonist.

  1998cited by this paper
• Comparison of the acute effects of a selective endothelin ETA and a mixed ETA/ETB receptor antagonist in heart failure.

  1998cited by this paper
• Increased cardiac and pulmonary endothelin-1 mRNA expression in canine pacing-induced heart failure.

  1998cited by this paper
• Transgenic expression of the endothelin-B receptor prevents congenital intestinal aganglionosis in a rat model of Hirschsprung disease.

  1998cited by this paper
• Hemodynamic and coronary effects of the endothelin antagonist bosentan in patients with coronary artery disease.

  1998cited by this paper
• Short-term haemodynamic effects of BQ-123, a selective endothelin ET(A)-receptor antagonist, in chronic heart failure.

  1998cited by this paper
• Bosentan in essential hypertension.

  1998cited by this paper
• Value of cardiopulmonary exercise testing and big endothelin plasma levels to predict short-term prognosis of patients with chronic heart failure.

  1998cited by this paper
• ETA Receptor Blockade Prevents Increased Tissue Endothelin-1, Vascular Hypertrophy, and Endothelial Dysfunction in Salt-Sensitive Hypertension

  1998cited by this paper
• Coordinated upregulation of the cardiac endothelin system in a rat model of heart failure.

  1998cited by this paper
• The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators.

  1998cited by this paper
• Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts.

  1998cited by this paper
• Prolonged exercise causes an increase in endothelin-1 production in the heart in rats.

  1998cited by this paper
• Beneficial effects of long-term selective endothelin type A receptor blockade in canine experimental heart failure.

  1998cited by this paper
• Comparison of plasma neurohormones in congestive heart failure patients with atrial fibrillation versus patients with sinus rhythm.

  1998cited by this paper
• Cytokine and lipopolysaccharide stimulation of endothelin-1 release from human internal mammary artery and saphenous vein smooth-muscle cells.

  1998cited by this paper
• ET(A) receptor blockade prevents increased tissue endothelin-1, vascular hypertrophy, and endothelial dysfunction in salt-sensitive hypertension.

  1998cited by this paper
• Effect of the endothelin family of peptides on human coronary artery smooth-muscle cell migration.

  1998cited by this paper
• EndothelinBreceptors are functionally important in mediating vasoconstriction in the systemic circulation in patients with left ventricular systolic dysfunction

  1998cited by this paper
• Prolonged exercise causes an increase in endothelin-1 production in the heart in rats.

  1998cited by this paper
• Endothelin-1 inhibits nitric oxide synthesis in vascular smooth muscle cells.

  1997cited by this paper
• Angiotensin II increases vascular and renal endothelin-1 and functional endothelin converting enzyme activity in vivo: role of ETA receptors for endothelin regulation.

  1997cited by this paper
• Isometric handgrip exercise increases endothelin-1 plasma levels in patients with chronic congestive heart failure.

  1997cited by this paper
• Endothelin-converting enzyme expression in the rat vascular injury model and human coronary atherosclerosis.

  1997cited by this paper
• Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study.

  1997cited by this paper
• Down-regulation of ET(B) receptor, but not ET(A) receptor, in congestive lung secondary to heart failure. Are marked increases in circulating endothelin-1 partly attributable to decreases in lung ET(B) receptor-mediated clearance of endothelin-1?

  1997cited by this paper
• Concomitant endothelin receptor subtype-A blockade during the progression of pacing-induced congestive heart failure in rabbits. Beneficial effects on left ventricular and myocyte function.

  1997cited by this paper
• Blood pressure and vascular effects of endothelin blockade in chronic nitric oxide-deficient hypertension.

  1997cited by this paper
• Comparison of the effects of selective endothelin ETA and ETB receptor antagonists in congestive heart failure.

  1997cited by this paper
• Increased cardiac expression of endothelin-1 mRNA in ischemic heart failure in rats.

  1997cited by this paper
• Prognostic value of plasma endothelin-1 in patients with chronic heart failure.

  1997cited by this paper
• Effects of chronic ETA-receptor blockade in angiotensin II-induced hypertension.

  1997cited by this paper
• Angiotensin II increases tissue endothelin and induces vascular hypertrophy: reversal by ET(A)-receptor antagonist.

  1997cited by this paper
• Cardiopulmonary effects of endothelin-1 in man.

  1997cited by this paper
• Angiotensin II Increases Vascular and Renal Endothelin-1 and Functional Endothelin Converting Enzyme Activityin Vivo:Role of ETAReceptors for Endothelin Regulation

  1997cited by this paper
• Inhibition of myocardial endothelin pathway improves long-term survival in heart failure

  1996cited by this paper
• Increased plasma endothelin-1 in heavy and light smokers.

  1996cited by this paper
• Endothelin and calcium antagonists in the skin microcirculation of patients with coronary artery disease.

  1996cited by this paper
• Increased activation of sympathetic nervous system and endothelin by mental stress in normotensive offspring of hypertensive parents.

  1996cited by this paper
• Exogenous effects and endogenous production of endothelin in cardiac myocytes: potential significance in heart failure.

  1996cited by this paper
• Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure.

  1996cited by this paper
• A homozygous mutation in the endothelin-3 gene associated with a combined Waardenburg type 2 and Hirschsprung phenotype (Shah-Waardenburg syndrome)

  1996cited by this paper
• Changes in plasma endothelin-1 levels reflect clinical response to beta-blockade in chronic heart failure.

  1996cited by this paper
• Human pulmonary circulation is an important site for both clearance and production of endothelin-1.

  1996cited by this paper
• Mild hypoxia induces hypertrophy of cultured neonatal rat cardiomyocytes: a possible endogenous endothelin-1-mediated mechanism.

  1996cited by this paper
• Pulmonary clearance of circulating endothelin-1 in dogs in vivo: exclusive role of ETB receptors.

  1996cited by this paper
• Plasma endothelin in congestive heart failure: effect of the ACE inhibitor, fosinopril.

  1996cited by this paper
• Vasodilator effects of endothelin-converting enzyme inhibition and endothelin ETA receptor blockade in chronic heart failure patients treated with ACE inhibitors.

  1996cited by this paper
• Sympathomimetic modulation of load-dependent changes in the action potential duration in the in situ porcine heart.

  1996cited by this paper
• Physical training improves endothelial function in patients with chronic heart failure.

  1996cited by this paper
• Bosentan improves renal regional blood flow in rats with experimental congestive heart failure.

  1996cited by this paper
• Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure. Marked increase in endothelin-1 production in the failing heart.

  1996cited by this paper
• Pulmonary hypertension caused by congestive heart failure is ameliorated by long-term application of an endothelin receptor antagonist. Increased expression of endothelin-1 messenger ribonucleic acid and endothelin-1-like immunoreactivity in the lung in congestive heart failure in rats.

  1996cited by this paper
• The progression from hypertension to congestive heart failure.

  1996cited by this paper
• Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure.

  1995cited by this paper
• Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure.

  1995cited by this paper
• Pharmacology of a non‐selective ETA and ETB receptor antagonist, TAK‐044 and the inhibition of myocardial infarct size in rats

  1995cited by this paper
• Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque. A clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina.

  1995cited by this paper
• Endothelin‐1 as an Autocrine Growth Factor for Endothelial Cells

  1995cited by this paper
• Genetic Variability of the ET‐1 and the ETA Receptor Genes in Essential Hypertension

  1995cited by this paper
• Endothelin ETA and ETB receptors cause vasoconstriction of human resistance and capacitance vessels in vivo.

  1995cited by this paper
• Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.

  1995cited by this paper
• Role of Endogenous Endothelin in the Extension of Myocardial Infarct Size Studied with the Endothelin Receptor Antagonist, TAK‐044

  1995cited by this paper
• ETB-mediated regulation of extracellular levels of endothelin-1 in cultured human endothelial cells.

  1995cited by this paper
• Aortic arch malformations and ventricular septal defect in mice deficient in endothelin-1.

  1995cited by this paper
• In vitro effect of endothelin-1 on collagen, and ADP-induced aggregation in human whole blood and platelet rich plasma.

  1995cited by this paper
• Role of endothelin in the exercise intolerance of chronic heart failure.

  1995cited by this paper
• Endothelin Receptor Subtype B Mediates Autoinduction of Endothelin-1 in Rat Mesangial Cells (*)

  1995cited by this paper

• Endothelin-Antagonisten in der neurohumoralen Therapie der chronischen Herzinsuffizienz

  2020cites this paper
• Whole exome sequencing identifies mutation of EDNRA involved in ACTH-independent macronodular adrenal hyperplasia

  2013cites this paper
• Integrated control of pulmonary vascular tone by endothelin and angiotensin II in exercising swine depends on gender.

  2010cites this paper
• ZFP260 Is an Inducer of Cardiac Hypertrophy and a Nuclear Mediator of Endothelin-1 Signaling*

  2010cites this paper
• Expression of endothelin receptor subtypes in bronchial tumors.

  2009cites this paper
• Control of pulmonary vascular tone during exercise in health and pulmonary hypertension.

  2008cites this paper
• Integrative control of coronary resistance vessel tone by endothelin and angiotensin II is altered in swine with a recent myocardial infarction.

  2008cites this paper
• Stimulus-response specificity of human conduit artery flow mediated dilation

  2007cites this paper
• Endothelin receptors as drug targets in chronic cardiovascular diseases: the rationale for dual antagonism

  2006cites this paper
• Attenuation of proinflammatory gene expression and microcirculatory disturbances by endothelin A receptor blockade after orthotopic liver transplantation in pigs.

  2006cites this paper
• The relationship between shear stress and flow‐mediated dilatation: implications for the assessment of endothelial function

  2005cites this paper
• Contribution of endothelin to coronary vasomotor tone is abolished after myocardial infarction.

  2005cites this paper
• Effects of ETA Receptor Antagonism on Proinflammatory Gene Expression and Microcirculation Following Hepatic Ischemia/Reperfusion

  2005cites this paper
• Effects of Acute Systemic Endothelin Receptor Blockade on Cardiac Electrophysiology In Vivo

  2004cites this paper
• Proteases and Arrhythmias

  2003cites this paper
• Association of EDNRA, but not WNK4 or FKBP1B, polymorphisms with essential hypertension

  2003cites this paper
• Selective Upregulation of Endothelin B Receptor Gene Expression in Severe Pulmonary Hypertension

  2002cites this paper
• Bedeutung von inhalativem Stickstoffmonoxid (iNO) für die Behandlung der pulmonalen Hypertonie Neugeborener

  2002cites this paper
• BMS-193884 and BMS-207940 Bristol-Myers Squibb.

  2002cites this paper
• Endothelin-Antagonisten in der neurohumoralen Therapie der chronischen Herzinsuffizienz

  2002cites this paper